UBRELVY® NOW HAS EXPANDED COVERAGE FOR YOUR PATIENTS1*

LOOK UP INSURANCE PLANS FOR UBRELVY IN YOUR AREA*


Select a filter
Please enter a valid ZIP code.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • PLAN NAME
  • CHANNEL
  • COVERAGE DETAILS

*Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of August 2024 and subject to change.

Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.

Definitions:

PA: Prior Authorization; PA criteria may include diagnosis and trial and failure of one or more oral generic triptans.

ST: Step Therapy; ST may require trial and failure of one or more acute treatments.

Preferred: UBRELVY is on a preferred tier or otherwise has preferred status on the plan's formulary.

Map of the United States showing 97% of commercially insured lives are covered for UBRELVY and 56% of commercially insured lives are unrestricted or require 0 or 1 prior therapy access to UBRELVY

*Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of October 2024, December 2024, and subject to change.

Unrestricted implies no step edit.

Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.

UBRELVY is covered for 81% of Medicare Part D lives

OF MEDICARE PART D LIVES ARE NOW COVERED FOR UBRELVY 1*

*Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of December 2024 and subject to change.

Unrestricted implies no step edit.

Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.

IN A 2024 SURVEY

99%

OF CURRENT UBRELVY USERS SAID THEY PLAN TO CONTINUE TAKING UBRELVY

 

Source: Online survey conducted by Ipsos Healthcare on behalf of AbbVie Inc., between August 20, 2024, and September 24, 2024, among 500 adults aged 18-64, of which 200 were using UBRELVY at the time of the survey.

§Survey respondents could choose from yes or no to indicate their agreement with the provided statement. The percentage represents those who answered yes.

PATIENTS CAN SAVE WITH UBRELVY COMPLETE

UBRELVY Complete is designed to give your patients the support and resources they need to help them through every step of treatment with UBRELVY.

UBRELVY savings card

Not actual card.

MORE OF YOUR UBRELVY PATIENTS MAY SAVE THAN YOU EXPECT

95%

OF ELIGIBLE COMMERCIALLY INSURED PATIENTS PAY $0 FOR UBRELVY WITH THEIR UBRELVY COMPLETE SAVINGS CARD1‡

 

For access and reimbursement questions, contact your Field Reimbursement Manager

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs), or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit UBRELVY.com/savings-terms or call 1-844-482-7358 for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.

Msg and data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.

Data on file. AbbVie Inc. (Savings card redemption data as of January 2024–December 2024 and subject to change.)